CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $136K of Crinetics Pharmaceuticals, Inc.
Sold$136,110
$45.37Price
3,000Shares
−4%Stake
What CRNX did after the filing
- The stock from Wed, Jun 26 close, $42.19
- +20.3%
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Aug 8 close.
Traded Tue, Jun 25. Filed Wed, Jun 26, 12:32 PM ET, during the session. Returns use the Jun 26 close and the Aug 8 close. Not investment advice.